Related Experiment Videos
[Systemic effects of beta blockaders used in collyria]
1Clinique cardiologique, Centre hospitalier général de Vendôme.
Presse Medicale (Paris, France : 1983)
|June 18, 1988
Summary
Beta-blocker eye drops effectively lower intraocular pressure for glaucoma. However, they can cause systemic side effects, necessitating careful patient monitoring for cardiac or respiratory issues.
Area of Science:
- Ophthalmology
- Pharmacology
Context:
- Beta-blocker eye drops are a common treatment for chronic glaucoma.
- They effectively reduce intraocular pressure by 25-30%.
Purpose:
- To highlight the systemic effects of topical beta-blockers used in glaucoma treatment.
- To inform clinicians about potential cardiovascular and respiratory side effects.
Summary:
- Topical beta-blockers are absorbed via the nasal mucosa, bypassing liver metabolism.
- This leads to systemic absorption and potential side effects similar to oral administration.
- While generally well-tolerated, these effects can be serious in patients with pre-existing conditions.
Impact:
- Emphasizes the need for careful patient selection and monitoring when prescribing beta-blocker eye drops.
- Recommends consideration of patient's cardio-respiratory status and concurrent medications.
- Promotes safer prescribing practices for glaucoma management.